
PhaseBio To Report First Quarter 2019 Financial Results and Recent Corporate Progress on May 9, 2019
MALVERN, PA — PhaseBio Pharmaceuticals, Inc. (Nasdaq: PHAS), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapies for orphan diseases, announced it will report financial and business results …
Read More